发明名称 Microfabricated nanopore device for sustained release of therapeutic agent
摘要 A drug delivery device that includes a capsule for implantation into the body; the capsule further includes a reservoir for containing a substance such as a therapeutic agent, at least one port for allowing the substance to diffuse from or otherwise exit the reservoir, and a nanopore membrane in communication with the capsule at or near the exit port for controlling the rate of diffusion of the substance from the exit port. The device also includes an optional screen for providing structural stability to the nanopore membrane and for keeping the pores of the nanopore membrane clear. One embodiment of the drug delivery device includes an osmotic engine internal to the device for creating fluid flow through the device.
申请公布号 US9066876(B2) 申请公布日期 2015.06.30
申请号 US201314083220 申请日期 2013.11.18
申请人 Delpor, Inc. 发明人 Martin Francis J.;Boiarski Anthony A.
分类号 A61K9/22;A61K9/48;A61M5/142;A61K9/16;A61K9/00;A61M5/168;A61K38/27;A61M31/00 主分类号 A61K9/22
代理机构 McDermott Will & Emery LLP 代理人 Mohr Judy M.;McDermott Will & Emery LLP
主权项 1. A method for delivering a therapeutic agent, comprising: providing a device comprising a fluid impermeable wall defining a reservoir that contains a therapeutic agent with molecular dimensions; said capsule further comprising an exit port in communication with the reservoir and a nanopore membrane in communication with the exit port, wherein said nanopore membrane comprises an array of annular pores, each pore in the array having a diameter of between about 2-100 nm and dimensioned to be between about 1-5 times the molecular dimensions of the therapeutic agent, and wherein said therapeutic agent is released by diffusion across said array of annular pores at a rate that approaches zero-order for a period of about several weeks to about six months, said device being indicated for implantation.
地址 San Francisco CA US